Literature DB >> 18537709

Indolo[3,2-b]quinolines: synthesis, biological evaluation and structure activity-relationships.

Eyunni V K Suresh Kumar1, Jagan R Etukala, Seth Y Ablordeppey.   

Abstract

The tetracyclic indolo[3,2-b]quinoline ring system constitutes an important structural moiety in natural products exhibiting numerous biological activities. In particular, indolo [3, 2-b]quinoline, commonly known as linear quindoline is of particular interest, because of its rigid structure and scope of derivatization. Although the core linear quindoline skeleton shows little or no activity in several biological systems, introduction of a methyl group on the N-5 atom leading to cryptolepine induces remarkable activity against a broad spectrum of biological targets. A number of analogs of quindoline and cryptolepine have been synthesized, incorporating various functional groups on the core quindoline skeleton leading to improved biological activities. In this review, we describe various synthetic methodologies leading to the quindoline scaffold, the biological activities and the structure activity relationships (SAR) of quindoline derivatives toward different disease states to give a better picture of the importance of this moiety in medicinal chemistry.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18537709      PMCID: PMC3777419          DOI: 10.2174/138955708784534418

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  61 in total

1.  Effects of cryptolepine alone and in combination with dipyridamole on a mouse model of arterial thrombosis.

Authors:  A O Oyekan; J P Okafor
Journal:  J Ethnopharmacol       Date:  1989-11       Impact factor: 4.360

2.  New synthesis of benzo-delta-carbolines, cryptolepines, and their salts: in vitro cytotoxic, antiplasmodial, and antitrypanosomal activities of delta-carbolines, benzo-delta-carbolines, and cryptolepines.

Authors:  E Arzel; P Rocca; P Grellier; M Labaeïd; F Frappier; F Guéritte; C Gaspard; F Marsais; A Godard; G Quéguiner
Journal:  J Med Chem       Date:  2001-03-15       Impact factor: 7.446

3.  Synthetic cryptolepine inhibits DNA binding of NF-kappaB.

Authors:  Olumayokun A Olajide; Elke H Heiss; Daniel Schachner; Colin W Wright; Angelika M Vollmar; Verena M Dirsch
Journal:  Bioorg Med Chem       Date:  2006-10-24       Impact factor: 3.641

4.  The alpha-adrenoceptor blocking properties of cryptolepine on the rat isolated vas deferens. Studies on cryptolepine.

Authors:  B K Noamesi; S O Bamgbose
Journal:  Planta Med       Date:  1980-05       Impact factor: 3.352

5.  In vitro antibacterial screening of Cryptolepis sanguinolenta alkaloids.

Authors:  A Paulo; A Duarte; E T Gomes
Journal:  J Ethnopharmacol       Date:  1994-10       Impact factor: 4.360

6.  Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents.

Authors:  C W Wright; J Addae-Kyereme; A G Breen; J E Brown; M F Cox; S L Croft; Y Gökçek; H Kendrick; R M Phillips; P L Pollet
Journal:  J Med Chem       Date:  2001-09-13       Impact factor: 7.446

7.  Effect of medium composition, agitation and the presence of EDTA on the antimicrobial activity of cryptolepine.

Authors:  I K Sawer; M I Berry; J L Ford
Journal:  Lett Appl Microbiol       Date:  1997-09       Impact factor: 2.858

8.  Identification of bis-quindolines as new antiinfective agents.

Authors:  Leroy G Mardenborough; Xue Y Zhu; Pincheng Fan; Melissa R Jacob; Shabana I Khan; Larry A Walker; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2005-06-02       Impact factor: 3.641

9.  Interactions of cryptolepine and neocryptolepine with unusual DNA structures.

Authors:  Lionel Guittat; Patrizia Alberti; Frédéric Rosu; Sabine Van Miert; Emilie Thetiot; Luc Pieters; Valérie Gabelica; Edwin De Pauw; Alexandre Ottaviani; Jean-François Riou; Jean-Louis Mergny
Journal:  Biochimie       Date:  2003-05       Impact factor: 4.079

10.  Role of the endothelium and cyclic GMP in renal vasodilator responses to cryptolepine in rats.

Authors:  A O Oyekan
Journal:  J Cardiovasc Pharmacol       Date:  1994-04       Impact factor: 3.105

View more
  12 in total

1.  Antileishmanial activity of cryptolepine analogues and apoptotic effects of 2,7-dibromocryptolepine against Leishmania donovani promastigotes.

Authors:  Sudipta Hazra; Subhalakshmi Ghosh; Sukalyani Debnath; Scott Seville; Vijay Kumar Prajapati; Colin W Wright; Shyam Sundar; Banasri Hazra
Journal:  Parasitol Res       Date:  2012-07       Impact factor: 2.289

2.  Identification of 3-phenylaminoquinolinium and 3-phenylaminopyridinium salts as new agents against opportunistic fungal pathogens.

Authors:  Tryphon K Mazu; Jagan R Etukala; Xue Y Zhu; Melissa R Jacob; Shabana I Khan; Larry A Walker; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2010-11-05       Impact factor: 3.641

3.  Benzothieno[3,2-b]quinolinium and 3-(phenylthio)quinolinium compounds: Synthesis and evaluation against opportunistic fungal pathogens.

Authors:  Comfort A Boateng; Suresh V K Eyunni; Xue Y Zhu; Jagan R Etukala; Barbara A Bricker; M K Ashfaq; Melissa R Jacob; Shabana I Khan; Larry A Walker; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2010-11-10       Impact factor: 3.641

4.  δ-Carbolines and their ring-opened analogs: synthesis and evaluation against fungal and bacterial opportunistic pathogens.

Authors:  Tryphon K Mazu; Jagan R Etukala; Melissa R Jacob; Shabana I Khan; Larry A Walker; Seth Y Ablordeppey
Journal:  Eur J Med Chem       Date:  2011-03-17       Impact factor: 6.514

5.  Optimization of 3-(phenylthio)quinolinium compounds against opportunistic fungal pathogens.

Authors:  Comfort A Boateng; Xue Y Zhu; Melissa R Jacob; Shabana I Khan; Larry A Walker; Seth Y Ablordeppey
Journal:  Eur J Med Chem       Date:  2011-02-23       Impact factor: 6.514

Review 6.  The Mechanistic Targets of Antifungal Agents: An Overview.

Authors:  Tryphon K Mazu; Barbara A Bricker; Hernan Flores-Rozas; Seth Y Ablordeppey
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

7.  CoMFA studies and in vitro evaluation of some 3-substituted benzylthio quinolinium salts as anticryptococcal agents.

Authors:  Sidney Bolden; Comfort A Boateng; Xue Y Zhu; Jagan R Etukala; Suresh K Eyunni; Melissa R Jacob; Shabana I Khan; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2013-09-03       Impact factor: 3.641

8.  Efficient Synthesis of 1,9-Substituted Benzo[h][1,6]naphthyridin-2(1H)-ones and Evaluation of their Plasmodium falciparum Gametocytocidal Activities.

Authors:  Hao Li; Wei Sun; Xiuli Huang; Xiao Lu; Paresma R Patel; Myunghoon Kim; Meghan J Orr; Richard M Fisher; Takeshi Q Tanaka; John C McKew; Anton Simeonov; Philip E Sanderson; Wei Zheng; Kim C Williamson; Wenwei Huang
Journal:  ACS Comb Sci       Date:  2017-10-27       Impact factor: 3.784

9.  An intramolecular inverse electron demand Diels-Alder approach to annulated α-carbolines.

Authors:  Zhiyuan Ma; Feng Ni; Grace H C Woo; Sie-Mun Lo; Philip M Roveto; Scott E Schaus; John K Snyder
Journal:  Beilstein J Org Chem       Date:  2012-06-06       Impact factor: 2.883

10.  Synthesis and In Vitro Antiproliferative Activity of 11-Substituted Neocryptolepines with a Branched ω-Aminoalkylamino Chain.

Authors:  Elkhabiry Shaban; Marta Świtalska; Li Wang; Ning Wang; Fan Xiu; Ikuya Hayashi; Tran Anh Ngoc; Sachie Nagae; Samah El-Ghlban; Shiho Shimoda; Ahmed Abdel Aleem El Gokha; Ibrahim El Tantawy El Sayed; Joanna Wietrzyk; Tsutomu Inokuchi
Journal:  Molecules       Date:  2017-11-12       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.